Today, an analyst has provided a rating update for WELL Health Technologies Corp (WELL – Research Report). Echelon Wealth Partners’ analyst Rob Goff reiterates their Buy rating on the shares, with a C$8.00 price target.
Goff has an average return of 4.1% when recommending WELL Health Technologies Corp.
According to TipRanks.com, Goff is ranked #247 out of 8601 analysts.
Currently, the analyst consensus on WELL Health Technologies Corp is a Strong Buy with an average price target of C$8.80.
The company has a one-year high of C$5.94 and a one-year low of C$2.56. Currently, WELL Health Technologies Corp has an average volume of 729K.
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: Clinical services, Digital services, and others. It also engages in the Electronic Medical Records business that supports the digitization of clinics. Its objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.
The company’s shares closed last Wednesday at C$4.21.
Read More on TSE:WELL:
- WELL Health’s Cycura Announces Two Tuck-In Acquisitions to Enhance Patient Data Protection and Appoints New Management
- WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection and Preventative Care Tools for Care Providers
